Skip to main content
. 2022 Feb 21;12:818868. doi: 10.3389/fonc.2022.818868

Figure 11.

Figure 11

Analysis of immunotherapeutic responses between different risk groups. (A) Expression of ICIs in different risk groups. (B) The correlation between risk score and PD-1 expression. (C) The correlation between risk score and CTLA4 expression. (D) IPS scoring scheme estimates the potential responses to immunotherapy in different risk groups *P < 0.05; ***P < 0.001.